Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Urology|August 1, 1991
Transurethral resection of prostate under sedation and local anesthesia (sedoanalgesia). Experience in 100 patientsB R Birch, J S Gelister, C J Parker, et al.
The Journal of Urology|November 17, 1998
Intravesical chemotherapy with gamma linolenic acid becomes a realistic prospect in serum-free applications: in vitro cytotoxicity and systemic absorption studiesL Z Solomon, A M Jennings, P Sharpe, et al.
BJU International|November 9, 2000
A model of superficial bladder cancer using fluorescent tumour cells in an organ-culture systemT J Crook, I S Hall, L Z Solomon, et al.
British Journal of Urology|February 1, 1994
Flexible cystoscopy in men: is topical anaesthesia with lignocaine gel worthwhile?B R Birch, P Ratan, R Morley, et al.
British Journal of Urology|August 12, 1998
Bladder cancer recurrence by implantation of exfoliated cells: is gamma-linolenic acid an effective tumoricidal agent?L Z Solomon, A M Jennings, S J Foley, et al.
Urological Research|April 11, 2002
The effects of meglumine gamma linolenic acid (MeGLA) on an organ culture model of superficial bladder cancerT J Crook, J P Dyer, R I McCormick, et al.
BJU International|April 12, 2000
Nonhomologous bioinjectable materials in urology: 'size matters'?L Z Solomon, B R Birch, A J Cooper, et al.
European Urology|March 24, 1999
Estramustine reversal of resistance to intravesical epirubicin chemotherapyA M Jennings, L Z Solomon, P Sharpe, et al.
Urological Research|April 16, 1998
Is gamma-linolenic acid an effective intravesical agent for superficial bladder cancer? In vitro cytotoxicity and in vivo tolerance studiesL Z Solomon, A M Jennings, M C Hayes, et al.
European Urology|July 18, 2002
Intravesical meglumine gamma-linolenic acid in superficial bladder cancer: an efficacy studyN M Harris, T J Crook, J P Dyer, et al.
Pageof 3